-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DCCGAdm1+h2AwxcJ7Aq/yl+FpHZAFvXODiqfljPhjnWIuUUIQaLGybiYn4J75nEF OISZsEeBoc0ZHygxTXTBvQ== 9999999997-09-005592.txt : 20090304 9999999997-09-005592.hdr.sgml : 20090304 20090304154758 ACCESSION NUMBER: 9999999997-09-005592 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090304 DATE AS OF CHANGE: 20090304 20090304 20090304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-157322 FILM NUMBER: 09655469 BUSINESS ADDRESS: STREET 1: 850 BEAR TAVERN ROAD STREET 2: SUITE 201 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 850 BEAR TAVERN ROAD STREET 2: SUITE 201 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0X(#`@;V)J#3P\+TQI;F5A-IB M8&#@9&!@?L(`!&*M#*B`"8A9&#@.H`AR0C$#@S(##R_C9/$##,&SDG@9KC$M M@&F2G0_5;`7$C`P,4ID0FMD,;@H;`X/N1X@HPW>```,`>RT*NPT*96YDF4@-#@O5'EP92]84F5F/CYS=')E M86T-"GC:8F)B9&!B8&`7!E+T-A=&%L;V"/3-//R^7D9+@8R0T]4,T)BC_1%^G:[NY"N$#_?WR\UF M^;`:-NF>FZ0GDU28]$T2N'V3]]-U^!6%WV!)Z!LT_4[)`T& M(^V?LPE.;`(9`$)-R^G3>5C/YFNXTXV)MIZNHN7J#AU>+22G-PZYTB%$"_WOL,HSJ]>FYZBT$L]%K".N\X[9YEX53^Z"DRP_[Q`_<9U'>"LP3H M@=;FH#INQ9#7-4LASE7UM!!-`*D4._%-E[J-5./#(>-)7/,BAV.>LA+61XRG M@XVA9/\<657S_$E2EMVHA^6HPE%@OU#.J2B9=:$,19 M$+\7HHF4P',U()KR1A+A-;"?G0/>R2AQ&@=$\[`:>]DQ19=W9?&L3S2H]PSF M/_=\BR!U`3&L<9;I!M&>>%67RL";X'1MR2`7C6E3QS43T((Y[ET4I32T,0CL M4'NIG&3;\AB7KRBLL>Q>YG#[(@/]Z^KI0/QW2[-3A6MIMW&EF)3L4+(*N4I/ M*]B^PIEB)JB8D_NDP[0E)B6FUP96Z:K>QQC(/:^&4_7/,K>F&U.ZZV MC*L$[D4UKD`(I5%)AH-G&>,R$:.BQ-#F<2X'0T)0YQ9QS8"-AG3JS#HCP4C2P7TF<&>XQ.RFHF:?(<$YL74LU= M*+K$D8:L0NW('HY;K.SL%5)>)5E1,2PK$V":)$698E%GKV.LLJ9Z!-F>M+`* M/.]:8$6E26]W1985+Z(_,%5PCUKUJ/=(^ARF?-92.!`RMYD2JCU8$E?,=9^NE*X0T+0K MO(\_;1O"$\#!D]IP7;?95N_+XOBT[[4-*MH&N7+IH=8E>77[=-Z[?I)WVT?O M^MJUD443XE"5(Z^$FL>BB;R1=Y=DMTNR/)\)7I])<[K`@+K'F,ZR.L:Y4O2U M*C$43J?G%*7Q%,O3[5COBY+7KY^&_:;_(]74_O"23IV/E[@?+_'.LB%OC]3$ M`WWR1E*S..<,NY[,QQVVKKPZM.?Y!>CIA*#BDM'SMD7;"!RB'10CH[BX6JY&E5J`WNS;Y#@>=E=CT[P\7\EZ^,E9'C) M/!K])\``;()KV0T*96YD]W]IG[W/WV7N?M2X`)$\?+B\%E@(@F2?@!WHXTU>%1]"Q_0`& M>(`!I@`P6>FIOD'NP4`D+S<7>KK("?R+W@P!2/R^9>CI3Z>#_T_2K%2^``#( M7\3F;$XZ2\3Y(D[*%*2*[3,BIL8DBAE&B9DO2E#$ M6\3BG%/9R6PQ]XAX>X:0(V+$1\0%&5Q.IHAOBU@S29C,%?%;<6PRAYD.`(HD MM@LXK'@1FXB8Q`\.=!'Q<@!PI+@O..8+%G"R!.)#N:2D9O.YW(RDS@"@:$_DY7(Y+/I+BG)J4Q>-@"+9_XL&7%MZ:(B6YI:6UH:FAF9 M?E&H_[KX-R7N[2*]"OC<,XC6]X?MK_Q2Z@!@S(IJL^L/6\Q^`#JV`B!W_P^; MYB$`)$5]:[_QQ7EHXGF)%PA2;8R-,S,SC;@?!?W[KG")^)'.C?LP`OB!8!`.U@(6B`?)@`\R02[8#`I`$=@% M]H)*4`/J02-H`2=`!S@-+H#+X#JX">Z`!V`$C(/G8`:\`?,0!&$A,D2!Y"%5 M2`LR@,P@!F0/N4$^4"`4#D5#<1`/$D*YT!:H""J%*J%:J!'Z%CH%78"N0@/0 M/6@4FH)^A=[#"$R"J;`RK`T;PPS8"?:&@^$UT(%U(+W(+&4&F MD7U"W4*&H&]0E-1BNA#=`V M:"_T*G0<.A-=@"Y'-Z#;T)?0=]#CZ#<8#(:&T<%883PQX9@$S#I,,>8`IA5S M'C.`&:P!U@[KAV5B!=@"['[L,>PY["!V'/L61\2IXLQP[K@('`^7 MARO'->'.X@9Q$[AYO!1>"V^#]\.S\=GX$GP]O@M_`S^.GR=($W0(=H1@0@)A M,Z&"T$*X1'A(>$4D$M6)UL0`(I>XB5A!/$Z\0APEOB/)D/1)+J1(DI"TDW2$ M=)YTC_2*3"9KDQW)$60!>2>YD7R1_)C\5H(B823A)<&6V"A1)=$N,2CQ0A(O MJ27I)+E6,D>R7/*DY`W):2F\E+:4BQ13:H-4E=0IJ6&I66F*M*FTGW2R=+%T MD_15Z4D9K(RVC)L,6R9?YK#,19DQ"D+1H+A06)0ME'K*)5X*5])4"E=8I'5;J4YI55E'V4$Y5WJ]\47E:A:;BJ)*@ M4J9R5F5*E:)JK\I5+5,]I_J,+DMWHB?1*^@]]!DU)35/-:%:K5J_VKRZCGJ( M>IYZJ_HC#8(&0R-6HTRC6V-&4U735S-7LUGSOA9>BZ$5K[5/JU=K3EM'.TQ[ MFW:']J2.G(Z73HY.L\Y#7;*N@VZ:;IWN;3V,'D,O4>^`WDU]6-]"/UZ_2O^& M`6Q@:<`U.&`PL!2]U'HI;VG=TF%#DJ&3889AL^&H$XT\F%B9))O4F#TQE3%>8YIEVF?YJIF_&,JLRNVU.-G:?YRF<$R MSK*#R^Y:4"Q\+;99=%M\M+2RY%NV6$Y9:5I%6U5;#3.H#']&,>.*-=K:V7JC M]6GK=S:6-@*;$S:_V!K:)MHVV4XNUUG.65Z_?,Q.W8YI5VLW8D^WC[8_9#_B MH.;`=*AS>.*HXY;PKXNKA6NC: M[R;C%N)6Z?;87=T]SKW9?<;#PF.=QWE/M*>WYV[/82]E+Y97H]?,"JL5ZU?T M>).\@[PKO9_XZ/OP?;I\8=\5OGM\'Z[46LE;V>$'_+S\]O@]\M?Q3_/_/@`3 MX!]0%?`TT#0P-[`WB!(4%=04]";8.;@D^$&(;H@PI#M4,C0RM#%T+LPUK#1L M9)7QJO6KKH%)64K)2!5(/4@M21-)NTO6DS?&]^0SJ4OB:]4T`5_4SU"76%6X6C M&?8951EO,T,S3V9)9_&R^K+ULW=D3^2XYWR]#K6.M:X[5RUW<^[H>J?UM1N@ M#3$;NC=J;,S?.+[)8]/1S83-B9M_R#/)*\U[O25L2U>^=N[]]AOF/_CD^%[,)K129%Y44?BEG%U[XR_:KBJX6=L3O[ M2RQ+#N["[.+M&MKML/MHJ71I3NG8'M\][67TLL*RUWNC]EXM7U9>LX^P3[AO MI,*GHG._YOY=^S]4QE?>J7*N:JU6JMY1/7>`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`#`/>$ M\_L*#0IE;F1S=')E86T-96YD;V)J#34V(#`@;V)J#3P\+U-T96U6(#@R+T9O M;G1.86UE+U1I;65S3F5W4F]M86Y04TU4+T9O;G13=')E=&-H+TYO<:D#7JX M6"H%40Y;0(6E5G@)BLY*I@0BE&(*KTR6,2RE!5\AU%K#E(%%DA"2&>C`RPKH MP,N1-:*13X%7`*+!*\`)!94H4(-76O@:J01\((6!;V%+^`A%(=@/+.K32*60 M1*,TE4MF0BG8A$$JG<%'"4;`!\]D@AGPK+#,@&F>37W\XI5;]/R\;I>? MSV9'-]6G+[$%L^WCYE:$@Q?D\=&D736MJW[4:.*X66Z]XZ>^6X_J][=9^&;=[]RU\Z\?S"^'^(WP&T>+N30_7;?=O<803[HG?MK\XK/. M/]8K?L7/VONVZQT>X&^,\>V]F_;>^7UV4"WP\&__T5 M1'^'C`X<'^V.^)0)7,WBS]7C#PZ:,I.@ MM0G:+$&;)VB+!&V9H)4B12Q3Q"I%K%,.DDD1VQ1QEB+.4\1%BKA,N2HI=U`E M74*5(DZ9H$J9H#ID@N;]QT!E!T=!G*>(4T:I4D:I4T:I/Q[E;P$&`-^]XL8- M"F5N9'-T7!E+U!A9V5S+TMI9'-;-3`@,"!273X^#65N9&]B:@TU(#`@;V)J M#3P\+U-U8G1Y<&4O6$U,+TQE;F=T:"`S.3DQ+U1Y<&4O365T861A=&$^/G-T MFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&UL;G,Z<&1F>#TB:'1T<#HO+VYS+F%D M;V)E+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@("`\<&1F>#I#;VUP86YY/E-% M0SPO<&1F>#I#;VUP86YY/@H@("`@("`@("`\<&1F>#I3;W5R8V5-;V1I9FEE M9#Y$.C(P,#DP,S`T,3&UL;G,Z>&%P/2)H='1P.B\O;G,N M861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AA<#I#&%P.D-R96%T;W)4 M;V]L/@H@("`@("`@("`\>&%P.DUO9&EF>41A=&4^,C`P.2TP,RTP-%0Q-3HS M-SHP-BTP-3HP,#PO>&%P.DUO9&EF>41A=&4^"B`@("`@("`@(#QX87`Z0W)E M871E1&%T93XR,#`Y+3`S+3`T5#$U.C,V.C4Y+3`U.C`P/"]X87`Z0W)E871E M1&%T93X*("`@("`@("`@/'AA<#I-971A9&%T841A=&4^,C`P.2TP,RTP-%0Q M-3HS-SHP-BTP-3HP,#PO>&%P.DUE=&%D871A1&%T93X*("`@("`@/"]R9&8Z M1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&%P34TZ&%P34TZ M"UD969A=6QT(B\^"B`@("`@("`@("`@ M(#PO6%N*2]#2A314,I+U-O=7)C94UO9&EF:65D*$0Z M,C`P.3`S,#0Q-S(U,#(I+U1I=&QE*"D^/@UE;F1O8FH->')E9@T*,"`T.`T* M,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`V.3,V(#`P,#`P(&X-"C`P,#`P M,# -----END PRIVACY-ENHANCED MESSAGE-----